03/04/2021 4:10 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2021 3:54 PM | G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/24/2021 4:16 PM | G1 Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/18/2021 4:49 PM | G1 Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2021 5:34 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/11/2021 12:07 PM | G1 Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/08/2021 9:23 AM | FMR LLC (Filed by) G1 Therapeutics (Subject)
| Form SC 13G/A
| |
02/03/2021 12:33 PM | G1 Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/29/2021 3:07 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2021 8:57 AM | BlackRock Inc. (Filed by) G1 Therapeutics (Subject)
| Form SC 13G/A
| |
|
01/22/2021 5:47 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/21/2021 4:31 PM | G1 Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2021 5:02 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/05/2021 5:25 PM | G1 Therapeutics (Issuer) G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:22 PM | G1 Therapeutics (Issuer) G1 Therapeutics (Issuer) Gupta Soma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:18 PM | G1 Therapeutics (Issuer) Hanson James S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:14 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:12 PM | G1 Therapeutics (Issuer) MURDOCK TERRY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:10 PM | Avagliano Mark (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2020 3:50 PM | G1 Therapeutics (Issuer) RUDNICK SETH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/23/2020 5:54 PM | G1 Therapeutics (Issuer) RUDNICK SETH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/17/2020 5:01 PM | G1 Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2020 3:50 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2020 4:30 PM | G1 Therapeutics (Issuer) RUDNICK SETH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2020 3:20 PM | G1 Therapeutics (Issuer) RUDNICK SETH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/19/2020 3:54 PM | G1 Therapeutics (Issuer) MUIR GLENN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2020 3:33 PM | Bailey John E. Jr. (0001806147) (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/10/2020 9:27 AM | FMR LLC (Filed by) G1 Therapeutics (Subject)
| Form SC 13G/A
| |
11/04/2020 4:15 PM | G1 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/04/2020 3:05 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2020 3:08 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/09/2020 8:10 AM | G1 Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
09/08/2020 7:38 PM | G1 Therapeutics (Issuer) Hanson James S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/30/2020 3:17 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2020 3:42 PM | G1 Therapeutics (Issuer) Schwalm Cynthia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2020 3:40 PM | G1 Therapeutics (Issuer) RUDNICK SETH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2020 3:39 PM | G1 Therapeutics (Issuer) MUIR GLENN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2020 3:38 PM | G1 Therapeutics (Issuer) Nicholson Garry A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2020 3:37 PM | Deese Willie A (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2020 3:34 PM | Bailey John E. Jr. (0001806147) (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2020 3:32 PM | ESHELMAN FREDRIC N (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2020 5:08 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2020 4:16 PM | G1 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2020 3:05 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2020 3:53 PM | G1 Therapeutics (Issuer) Gupta Soma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2020 3:52 PM | G1 Therapeutics (Issuer) Gupta Soma (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/16/2020 6:00 AM | G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/16/2020 6:00 AM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/16/2020 6:00 AM | G1 Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/11/2020 3:44 PM | G1 Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
02/11/2020 3:20 PM | G1 Therapeutics (Subject) Hatteras Venture Partners IV SBIC, LP (Filed by)
| Form SC 13G/A
| |
02/03/2020 4:21 PM | G1 Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/28/2020 10:49 AM | G1 Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A
| |
01/24/2020 3:59 PM | G1 Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2020 3:58 PM | G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2020 3:58 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2020 5:12 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/23/2019 3:31 PM | G1 Therapeutics (Filer)
| Form 8-K/A
| |
11/05/2019 4:16 PM | G1 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/05/2019 3:07 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2019 4:29 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2019 8:56 PM | G1 Therapeutics (Subject) Lumira Capital Investment Management Inc. (Filed by)
| Form SC 13G/A
| |
08/07/2019 4:16 PM | G1 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/30/2019 3:29 PM | Avagliano Mark (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/30/2019 3:28 PM | Avagliano Mark (Reporting) G1 Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/19/2019 8:58 PM | G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2019 5:05 AM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2019 3:38 PM | ESHELMAN FREDRIC N (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:36 PM | G1 Therapeutics (Issuer) RUDNICK SETH (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:35 PM | Deese Willie A (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:33 PM | G1 Therapeutics (Issuer) Nicholson Garry A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:32 PM | G1 Therapeutics (Issuer) MUIR GLENN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:31 PM | G1 Therapeutics (Issuer) Schwalm Cynthia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2019 3:30 PM | G1 Therapeutics (Issuer) WITTY ANDREW (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2019 3:26 PM | G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2019 4:16 PM | G1 Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019 3:26 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2019 3:10 PM | G1 Therapeutics (Filer)
| Form DEFA14A
| |
04/30/2019 3:05 PM | G1 Therapeutics (Filer)
| Form DEF 14A
| |
04/29/2019 3:07 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2019 3:34 PM | G1 Therapeutics (Filer)
| Form 10-K/A
| |
02/28/2019 3:08 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2019 3:51 PM | G1 Therapeutics (Subject) Hatteras Venture Partners IV SBIC, LP (Filed by)
| Form SC 13G/A
| |
01/28/2019 8:10 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2019 11:13 AM | FRANKLIN RESOURCES INC (Filed by) G1 Therapeutics (Subject)
| Form SC 13G/A
| |
01/17/2019 4:52 PM | G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2019 4:52 PM | G1 Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2019 8:37 AM | G1 Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G
| |
01/02/2019 4:46 PM | G1 Therapeutics (Issuer) Strum Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2019 4:32 PM | G1 Therapeutics (Issuer) Moses Jennifer K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2019 4:29 PM | G1 Therapeutics (Issuer) Hanson James S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2019 4:29 PM | G1 Therapeutics (Issuer) PHILLIPS BARCLAY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2019 4:29 PM | G1 Therapeutics (Issuer) MURDOCK TERRY L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2019 4:29 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2019 4:28 PM | DEMAREE JOHN (Reporting) G1 Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2019 4:28 PM | G1 Therapeutics (Issuer) Velleca Mark A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2018 3:59 PM | G1 Therapeutics (Issuer) Hanson James S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2018 3:59 PM | G1 Therapeutics (Issuer) Schwalm Cynthia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2018 4:24 PM | G1 Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/17/2018 3:27 PM | G1 Therapeutics (Issuer) Malik Rajesh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |